These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 16338090)
1. Alteration of activator protein 1 DNA binding activity in gentamicin-induced hair cell degeneration. Albinger-Hegyi A; Hegyi I; Nagy I; Bodmer M; Schmid S; Bodmer D Neuroscience; 2006 Feb; 137(3):971-80. PubMed ID: 16338090 [TBL] [Abstract][Full Text] [Related]
2. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway. Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736 [TBL] [Abstract][Full Text] [Related]
3. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells. Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907 [TBL] [Abstract][Full Text] [Related]
4. Effects of geldanamycin on signaling through activator-protein 1 in hypoxic HT29 human colon adenocarcinoma cells. Vasilevskaya IA; O'Dwyer PJ Cancer Res; 1999 Aug; 59(16):3935-40. PubMed ID: 10463587 [TBL] [Abstract][Full Text] [Related]
5. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells. Wu ZL; Wang YC; Zhou Q; Ge YQ; Lan Y Cell Biochem Funct; 2003 Sep; 21(3):249-56. PubMed ID: 12910478 [TBL] [Abstract][Full Text] [Related]
6. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress. Krysan K; Lou MF Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993 [TBL] [Abstract][Full Text] [Related]
7. Activation of transcription factor AP-1 and mitogen-activated protein kinases in aniline-induced splenic toxicity. Khan MF; Kannan S; Wang J Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):86-93. PubMed ID: 16169568 [TBL] [Abstract][Full Text] [Related]
8. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids. Testolin L; Carson C; Wang Y; Walker PR; Armato U; Sikorska M Exp Cell Res; 1997 Feb; 230(2):220-32. PubMed ID: 9024781 [TBL] [Abstract][Full Text] [Related]
9. Characterization of Cd-induced molecular events prior to cellular damage in primary rat hepatocytes in culture: activation of the stress activated signal protein JNK and transcription factor AP-1. Hsiao CJ; Stapleton SR J Biochem Mol Toxicol; 2004; 18(3):133-42. PubMed ID: 15252869 [TBL] [Abstract][Full Text] [Related]
10. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression. Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529 [TBL] [Abstract][Full Text] [Related]
11. Suppression of the c-Jun N-terminal kinase pathway by 17beta-estradiol can preserve human islet functional mass from proinflammatory cytokine-induced destruction. Eckhoff DE; Smyth CA; Eckstein C; Bilbao G; Young CJ; Thompson JA; Contreras JL Surgery; 2003 Aug; 134(2):169-79. PubMed ID: 12947315 [TBL] [Abstract][Full Text] [Related]
12. Ketamine inhibits tumor necrosis factor-alpha and interleukin-6 gene expressions in lipopolysaccharide-stimulated macrophages through suppression of toll-like receptor 4-mediated c-Jun N-terminal kinase phosphorylation and activator protein-1 activation. Wu GJ; Chen TL; Ueng YF; Chen RM Toxicol Appl Pharmacol; 2008 Apr; 228(1):105-13. PubMed ID: 18191973 [TBL] [Abstract][Full Text] [Related]
13. Estradiol protects the cochlea against gentamicin ototoxicity through inhibition of the JNK pathway. Nakamagoe M; Tabuchi K; Uemaetomari I; Nishimura B; Hara A Hear Res; 2010 Mar; 261(1-2):67-74. PubMed ID: 20074632 [TBL] [Abstract][Full Text] [Related]
15. In vivo anergized CD4+ T cells have defective expression and function of the activating protein-1 transcription factor. Sundstedt A; Dohlsten M J Immunol; 1998 Dec; 161(11):5930-6. PubMed ID: 9834073 [TBL] [Abstract][Full Text] [Related]
16. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork. Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381 [TBL] [Abstract][Full Text] [Related]
17. Minocycline prevents gentamicin-induced ototoxicity by inhibiting p38 MAP kinase phosphorylation and caspase 3 activation. Wei X; Zhao L; Liu J; Dodel RC; Farlow MR; Du Y Neuroscience; 2005; 131(2):513-21. PubMed ID: 15708492 [TBL] [Abstract][Full Text] [Related]
18. Mitogen activated protein kinase-dependent activation of c-Jun and c-Fos is required for neuronal differentiation but not for growth and stress response in PC12 cells. Eriksson M; Taskinen M; Leppä S J Cell Physiol; 2007 Feb; 210(2):538-48. PubMed ID: 17111371 [TBL] [Abstract][Full Text] [Related]
19. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Liu D; Gao L; Roy SK; Cornish KG; Zucker IH Circ Res; 2006 Oct; 99(9):1004-11. PubMed ID: 17008603 [TBL] [Abstract][Full Text] [Related]
20. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]